Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Pittsburgh, PA USA |
|
04/16/2008 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
Pittsburgh, PA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Pittsburgh, PA USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
Pittsburgh, PA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Hershey, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Wynnewood, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Bryn Mawr, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Allentown, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Paoli, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Reading, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Bethlehem, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
|
Pittsburgh, PA USA |
|
03/02/2008 |
|
|
|
Details |
|
NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma |
|
Pittsburgh, PA USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Pittsburgh, PA USA |
|
10/03/2007 |
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
08/26/2007 |
|
|
|
Details |
|
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
08/19/2007 |
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Philadelphi, PA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Pittsburgh, PA USA |
|
08/18/2007 |
|
|
|
Details |
|
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
|
Pittsburgh, PA USA |
|
08/04/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Wynnewood, PA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Pittsburgh, PA USA |
|
04/29/2007 |
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Philadelphia, PA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
Philadelphia, PA USA |
|
04/28/2007 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Philadelphia, PA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Pittsburgh, PA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Danville, PA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Danville, PA USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Allentown, PA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Pittsburgh, PA USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Hershey, PA USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma |
|
Pittsburgh, PA USA |
|
05/27/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Philadelphia, PA USA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Pittsburgh, PA USA |
|
05/27/2006 |
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
Pittsburgh, PA USA |
|
05/04/2006 |
|
|
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Philadelphia, PA USA |
|
05/01/2006 |
|
|
|
Details |
|
A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron)
for Plexiform Neurofibromas (NF1 patients) |
|
Pittsburgh, PA USA |
|
12/04/2005 |
|
|
|
|
|
Details |
|
Phase I/II Study of Multiple Light Fiber Interstitial Photodynamic Therapy for Primary and Metastatic Supratentorial Brain Tumors |
|
Hershey, PA USA |
|
12/03/2005 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Gliadel in Adults with Recurrent Malignant Gliomas |
|
Philadelphia, PA USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Danville, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Sayre, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Allentown, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
|
Philadelphia, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
|
Pittsburgh, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Hershey, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Philadelphia, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Pittsburgh, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Danville, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Philadelphia, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Philadelphia, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Pittsburgh, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
|
|
Philadelphia, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Pittsburgh, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
Philadelphia, PA USA |
|
11/27/2005 |
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
Pittsburgh, PA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Philadelphia, PA USA |
|
11/26/2005 |
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Pittsburgh, PA USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Philadelphia, PA USA |
|
11/26/2005 |
|
|
|
Details |
|
Phase I trial to study the effectiveness of combining paclitaxel with radiation therapy in treating children who have newly diagnosed brain stem glioma. |
|
Philadelphia, PA USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Reduced Dose Craniospinal Radiation (1800 cGy) and Chemotherapy in children with newly-diagnosed standard-risk posterior fossa primitive neuro-ectodermal tumor (PNET/medulloblastoma ) |
|
Philadelphia, PA USA |
|
11/26/2005 |
|
|
|
Details |
|
Gene Therapy Of Malignant Gliomas: A Pilot Study of Vaccination With Autologous Glioma-Lysate And Dendritic Cells Admixed With IL-4 Transduced Fibroblasts To Elicit An Immune Response. |
|
Pittsburgh, PA USA |
|
11/21/2005 |
|
|
|
|
|
Details |
|
FR901228 in Treating Patients With Recurrent High-Grade Gliomas |
|
Pittsburgh, PA USA |
|
11/13/2005 |
|
|
|
Details |
|
FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia |
|
Philadelphia, PA USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia |
|
Pittsburgh, PA USA |
|
11/11/2005 |
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Philadelphia, PA USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Pittsburgh, PA USA |
|
11/11/2005 |
|
|
|
Details |
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
|
Philadelphia, PA USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
|
Pittsburgh, PA USA |
|
11/11/2005 |
|
|
|
Details |
|
Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Pittsburgh, PA USA |
|
11/06/2005 |
|
|
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Wynnewood, PA USA |
|
11/06/2005 |
|
|
|
Details |
|
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme |
|
Pittsburgh, PA USA |
|
11/06/2005 |
|
|
|
|
|
